2,405 research outputs found
Lo sviluppo di sistemi di gestione del cliente pubblico nelle imprese farmaceutiche: il ruolo dei regional affairs e dei key account managers
No full textIl decentramento regionale, l’introduzione di sistemi di management nelle aziende sanitarie e l’aumento della quota di farmaci da queste direttamente acquistati implica che l’accesso al mercato per i medicinali dipenda sempre di più dalla capacità delle imprese di gestire le relazioni con le regioni e le aziende sanitarie. L’obiettivo della ricerca è quello di analizzare (i) su un pool di imprese farmaceutiche, l’organizzazione dell’attività dei public affairs a livello regionale e l’applicazione di logiche di key account management nelle relazioni con le aziende sanitarie, e (ii) su un gruppo di regioni, la percezione che i referenti delle regioni per la farmaceutica hanno del valore aggiunto e delle criticità generati dalle relazioni con le imprese. L’indagine è stata condotta sulla base di due questionari semistrutturati somministrati per tramite di intervista ai responsabili dei public affairs regionale e key account manager ed ai referenti regionali per la farmaceutica. A partire dai risultati della ricerca vengono discussi alcuni fattori che potrebbero aumentare nelle imprese le potenzialità di tali nuove funzioni, per rendere più efficace la gestione delle relazioni con il cliente pubblico
Postal de Claudio Vivas a Maruja Vieira, junio 23 de 1955
No full textPostal de Claudio Vivas a Maruja Vieira, felicitándola por el reconocimiento que le fue otorgado a la autora de poemasPostcard from Claudio Vivas to Maruja Vieira, congratulating her for the recognition given to the author of poems.Publicación, fondo Maruja Vieira, carpeta 1, folio
La spesa sanitaria: fonti informative, composizione ed evoluzione
No full textIl capitolo illustra i dati relativi alla spesa sanitaria nazionale e regionale, i dati dei disavanzi regionali e le misure implementate dalle regioni a parziale copertura di tali disavanzi. I dati nazionali sono, inoltra, confrontati con quelli degli altri paesi dell'Unione Europea e di altri paesi europei ed extraeuropei. Il capitolo effettua una dettagliata ricognizione delle fonti informative. L'aggiornamento è al 200
Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity
No full textIn Italy, the process of power decentralization to Regional Governments has particularly affected pharmaceutical care policies.
Regions are experimenting with various strategies to govern drugs utilization and expenditure, and differentiating their
approaches, leading to an ever-changing and complex institutional scenario.
Pharmaceutical companies have created new professional roles, the Regional Affairs Managers (RAM), with the mandate
to monitor the different regional contexts and measures, and to establish relationships with the public actors in charge of
pharmaceutical policies.
This analysis shows how public affairs/lobbying actions at regional level and the creation of a solid political competence
within companies are still in an early phase. The activities carried out by RAMs remain limited to an exchange of information
and only rarely are perceived by Regional public servants (RRs) as giving support to their work or influence decisions.
The interaction with RAMs is often seen as little relevant and still too concentrated on products and a marketing/commercial
approach rather than on broader issues of interest to RRs who need to manage the pharmaceutical care system at large. The
level of acceptance of this type of activity is also variable and RRs’ attitudes alternate between diffidence, polite tolerance, and
openness to a constructive dialogue about pharmaceuticals and their management in a regional healthcare system.
© 2008 Elsevier Ireland Ltd. All rights reserved
Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity
No full textIn Italy, the process of power decentralization to Regional Governments has particularly affected pharmaceutical care policies.
Regions are experimenting with various strategies to govern drugs utilization and expenditure, and differentiating their
approaches, leading to an ever-changing and complex institutional scenario.
Pharmaceutical companies have created new professional roles, the Regional Affairs Managers (RAM), with the mandate
to monitor the different regional contexts and measures, and to establish relationships with the public actors in charge of
pharmaceutical policies.
This analysis shows how public affairs/lobbying actions at regional level and the creation of a solid political competence
within companies are still in an early phase. The activities carried out by RAMs remain limited to an exchange of information
and only rarely are perceived by Regional public servants (RRs) as giving support to their work or influence decisions.
The interaction with RAMs is often seen as little relevant and still too concentrated on products and a marketing/commercial
approach rather than on broader issues of interest to RRs who need to manage the pharmaceutical care system at large. The
level of acceptance of this type of activity is also variable and RRs’ attitudes alternate between diffidence, polite tolerance, and
openness to a constructive dialogue about pharmaceuticals and their management in a regional healthcare syste
- …
